Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income -298.97 K-182.27 K-166.64 K-154.69 K-212.98 K-273.34 K -807.64 K Non-Operating Income, Total 1.2 M1.22 M1.24 M1.17 M1.07 M995.03 K 4.48 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 1.2 M1.22 M1.24 M1.17 M1.07 M995.03 K 4.48 M Unusual income/expense —————— — Pretax income 905.99 K1.04 M1.08 M1.01 M857.7 K721.69 K 3.67 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 905.99 K1.04 M1.08 M1.01 M857.7 K721.69 K 3.67 M Discontinued operations —————— — Net income 905.99 K1.04 M1.08 M1.01 M857.7 K721.69 K 3.67 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 905.99 K1.04 M1.08 M1.01 M857.7 K721.69 K 3.67 M Basic earnings per share (Basic EPS) 0.060.060.070.060.050.05 0.23 Diluted earnings per share (Diluted EPS) 1.810.060.070.060.050.05 0.23 Average basic shares outstanding 4.54 M4.54 M4.54 M4.54 M4.54 M4.54 M — Diluted shares outstanding 4.54 M4.54 M4.54 M4.54 M4.54 M4.54 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —